Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 71 | 83 | +12 |
| Shares | 33.0M | 45.5M | +12.5M (+37.8%) |
| Value | $188.5M | $353.4M | +$164.8M (+87.4%) |
New holders (31)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (19)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| EAM Investors, LLC | 190,455 | $1.09M |
| Jane Street Group, LLC | 173,159 | $987.0K |
| DAFNA Capital Management LLC | 170,326 | $970.9K |
| Newtyn Management, LLC | 133,999 | $763.8K |
| HRT Financial LP | 126,147 | $719.0K |
| Qube Research & Technologies Ltd | 67,466 | $384.6K |
| Marshall Wace, LLP | 67,206 | $383.1K |
| Connor, Clark & Lunn Investment Management Ltd. | 43,225 | $246.4K |
| Squarepoint Ops LLC | 37,400 | $213.2K |
| 683 Capital Management, LLC | 33,800 | $192.7K |
| Man Group plc | – | $186.7K |
| LMR Partners LLP | 23,780 | $135.5K |
| Boothbay Fund Management, LLC | 20,232 | $115.3K |
| Diametric Capital, LP | 13,127 | $74.8K |
| Balyasny Asset Management LLC | 11,725 | $66.8K |
| Cubist Systematic Strategies, LLC | 6,309 | $36.0K |
| Point72 Middle East FZE | 5,713 | $32.6K |
| Point72 Asset Management, L.P. | 5,642 | $32.2K |
| Quantbot Technologies LP | 2,480 | $14.1K |